Risk Factor Analysis for Secondary Malignancy in Dexrazoxane-Treated Pediatric Cancer Patients

PURPOSE: Dexrazoxane has been used as an effective cardioprotector against anthracycline cardiotoxicity. This study intended to analyze cardioprotective efficacy and secondary malignancy development, and elucidate risk factors for secondary malignancies in dexrazoxane-treated pediatric patients. MAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyery, Kang, Hyoung Jin, Park, Kyung Duk, Koh, Kyung-Nam, Im, Ho Joon, Seo, Jong Jin, Lee, Jae Wook, Chung, Nack-Gyun, Cho, Bin, Kim, Hack Ki, Lee, Jae Min, Hah, Jeong Ok, Lee, Jun Ah, Lee, Young Ho, Park, Sang Kyu, Baek, Hee Jo, Kook, Hoon, Kim, Ji Yoon, Kim, Heung Sik, Kim, Hwang Min, Chueh, Hee Won, Park, Meerim, Yoon, Hoi Soo, Lee, Mee Jeong, Choi, Hyoung Soo, Ahn, Hyo Seop, Kawano, Yoshifumi, Park, Ji Won, Hahn, Seokyung, Shin, Hee Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333985/
https://www.ncbi.nlm.nih.gov/pubmed/29764117
http://dx.doi.org/10.4143/crt.2017.457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333985/
https://www.ncbi.nlm.nih.gov/pubmed/29764117
http://dx.doi.org/10.4143/crt.2017.457

Ejemplares similares